MAETZOLD DEREK J 13D and 13G filings for Castle Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-11 4:01 pm Sale |
2021-12-31 | 13G | Castle Biosciences, Inc. CSTL |
MAETZOLD DEREK J | 1,022,068 4.000% |
-633,207![]() (-38.25%) |
Filing |
2021-02-16 9:44 pm Sale |
2020-12-31 | 13G | Castle Biosciences, Inc. CSTL |
MAETZOLD DEREK J | 1,655,275 6.620% |
-297,940![]() (-15.25%) |
Filing |